Author: Shimrez Hyder

  • Datto Holding Corp. (MSP) Stock Trending Lower Following Disclosure of Q2 2021 Financial Reports

    Datto Holding Corp. (MSP) stock prices were down by a marginal 0.37% as of the market closing on August 13th 2021. This brought the price per share down to USD$27.21 at the end of the trading day. Subsequent premarket fluctuations saw the stock fall by 5.07%, bringing it down to USD$25.83.

    MSP Stock’s Stellar Quarter

    The second quarter of fiscal 2021 saw MSP stock report one of the strongest quarters in its history. The success of the quarter is a clear indication of the strength of the MSP business model. Subscription revenue growth was up 21% as compared to numbers from the prior year quarter. Q2 2021 also saw the company report the addition of 500 net new partners. Both the revenue growth and partner increase are the highest seen since the onset of the global coronavirus pandemic in early 2020.

    Scope of MSP Stock’s Expansion

    Based on its success, MSP stock expects to see strong momentum across all of its business segments. The company is keenly looking forward to launches in cloud and security that are expected for the second half of 2021. MSP has taken steps to position itself to adequately capitalize on the substantial opportunity to help its partners manage, protect, and connect and SMB client’s data in an increasingly digital world.

    Trajectory of Success

    MSP stock reported ending the second quarter of 2021 with more than 17,800 MSP partners. The net sequential increase of 500 partners was up from the increase of 300 partners in the first quarter of fiscal 2021. The number of MSPs contributing more than USD$100,000 ARR was up to 1,250, up from the 1,000 reported as of June 30th 2020.

    Consolidating Market Footprint

    Q2 2021 also saw MSP stock increase the number of endpoints enabled with Datoo RMM Ransomware Detection to more than one million globally. This is nearly double the numbers reported in May 2021. Further consolidating their steady growth was the Partner Security Firm, which MSP stock hosted. The event was attended by more than two thousand MSP Partners focused on security best practices. The company also announced the upcoming DattoCon21, which is expected to be held in the middle of October 2021.

    Future Outlook for MSP Stock

    The company reported a stellar end to the first half of fiscal 2021, with investors hoping the company will be able to continue its trajectory of success. Current and potential investors are hopeful that the company will be able to leverage the resources at their disposal. This is hoped to translate into significant and sustained increases in shareholder value.

  • Fortuna Silver Mines Inc. (FSM) Stock Trends Higher Following Promising Financial Reports for Q2 2021

    Fortuna Silver Mines Inc. (FSM) stock prices were up 4.29% as of the market close on August 13th, 2021. This brought the price per share up to USD$4.38 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 3.88%, bringing it up to USD$4.55.

    FSM Stock’s Sales Report

    The second quarter of fiscal 2021 saw FSM stock report USD$120.5 million in sales. This was a 171% increase from the USD$44.5 million reported in the second quarter of fiscal 2020. The higher sales were largely a result of a 58% increase in the volume of silver and a 52% increase in the volume of gold ounces sold. Further contributing to the year-over-year increase were higher realized metal prices, particularly of zinc and silver.

    Operating and Net Income

    Operating income for the 2021 quarter came out to USD$35.9 million, up from the operating loss of USD$1.3 million compared to the 2020 quarter. The year-over-year difference was largely attributable to the higher prices of gold and silver. Further consolidating the yearly difference was Lindero’s contribution to mine operating income in the amount of USD$7.2 million. Net income for the quarter ended June 30th, 2021 came out to USD$16.2 million. This is comparable to the USD$5.7 million net loss reported in Q2 2021.

    FSM Stock’s EBITDA Report

    Adjusted EBITDA for the second quarter of 2021 was reported at USD$54.9 million. FSM stock reported a massive improvement on the USD$9.4 million reported in the prior-year quarter. The year-over-year difference was largely driven by Lindero’s contribution to adjusted EBITDA in the amount of USD$16.2 million. Higher EBITDA contributions from the San Jose and Caylloma facilities further consolidated the year-over-year difference.

    Solid Liquidity Position

    FSM stock reported a solid liquidity position in the amount of USD$121.8 million in cash and cash equivalents. This is a decrease from the USD$131.9 million reported as of December 31st, 2020. This year-over-year difference was largely attributable to a USD$35.3 million promissory note that was provided to Roxgold. The promissory note served to cover a portion of the expected acquisition closing costs.

    Future Outlook for FSM Stock

    FSM stock reported a strong quarter with several promising developments. The company is keen to leverage the expanded resources at its disposal to facilitate consistent returns in shareholder value. Investors are confident in management’s ability to usher in a continued trajectory of growth.

  • ProPhase Labs Inc. (PRPH) Stock Trending Lower Following Disclosure of Q2 2021 Financial Reports

    ProPhase Labs Inc. (PRPH) stock prices were down by a marginal 0.46% as of the market close on August 13th, 2021. This brought the price per share down to USD$6.46 at the end of the trading day.

    PRPH Stock’s Acquisitions

    The second quarter of fiscal 2021 saw PRPH stock announce the acquisition of Nebula Genomics, a privately-owned personalized medicine genomics company. The company conducted the transaction through its wholly-owned subsidiary ProPhase Precision Medicine. The transaction is expected to see the company integrate Nebula’s whole genome sequencing services with its clinical diagnostic testing services. The testing services are conducted at the company’s CLIA-certified labs. Together, the joint solution is expected to be able to offer users a more complete genome mapping alternative to those currently available on the market.

    PRPH Stock’s Subsidiaries

    PRPH stock also announces the formation of two wholly-owned subsidiaries over the quarter. ProPhase Precision Medicine will focus on genomics testing technologies, while ProPhase Global Healthcare will seek to expand the company’s Covid-19 testing globally. The company was also awarded contracts with Dutchess County, New York, and Township of Oyster Bay. These contracts set PRPH stock up to provide reliable Covid-19 testing to almost 600,000 New York residents. ProPhase Labs expects to play a critical role in the return of the economy and normal functioning.

    Strong Financials

    Net revenue for the second quarter of fiscal 2021 came in at USD$9.1 million, up from the USD$3.6 million reported in the prior-year quarter. The year-over-year difference was largely driven by a USD$7.5 million increase related to the company’s new diagnostic services business. This difference was partially offset by a USD$2 million reductions in customer orders from its consumer products business. This reduction was largely attributable to timing and third-party demand.

    Solid Liquidity Position

    The company reported a solid liquidity position as of June 30th, 2021, with USD$35.8 million in cash and cash equivalents, and marketable debt securities. This is comparable to the USD$8.5 million reported as of December 31st, 2020. The sharp increase largely stems from the receipt of aggregate net proceeds in the amount of USD$40.6 million, from the company’s offerings.

    Future Outlook for PRPH Stock

    PRPH stock reported a strong quarter, the success of which it hopes to carry through to the next few quarters. The company is keen to continue its trajectory of success as it takes steps to usher in unprecedented growth. Investors are hopeful for significant and sustained increases in shareholder value.

  • Capricor Therapeutics Inc. (CAPR) Stock Trending Lower Following Announcement of Financial Reports for Q2 2021

    Capricor Therapeutics Inc. (CAPR) stock prices were down by 4% some time after market trading commenced on August 13th 2021. This brought the price per share down to USD$4.30 early on in the trading day.

    CAPR Stock’s CAP-1002

    The second quarter of fiscal 2021 saw CAPR stock report productive progress across the business ahead of a planned busy second half of 2021. The company reported a clear path forward for CAP-1002 for DMD as it prepares to initiate a pivotal study later in 2021. The final data has been submitted for publication, showing the significant impact of CAP-1002 on skeletal and cardiac muscle function in late-stage DMD patients. This is believed to further support the clinical path to potential approval.

    Expanded Workforce

    The positive momentum generated by the program has served to continue the advancement of the company’s partnering discussions. Furthermore, CAPR stock has made progress in its exosome program with the expansion of the team of seasoned biotech leaders. The team serves to bring a plethora of experience in engineering exosomes for therapeutic use. The company is now moving its multivalent exosome-mRNA vaccine towards the clinic. It is designed to be a booster to supplement currently available vaccines.

    CAPR Stock Addressing Covid-19 Efforts

    CAPR stock believes that their multiple protein approach has the potential to confer increased immunity protection against different strains of the Covid-19 virus. The quarter also saw the company ramp up enrollment for its INSPIRE clinical trial for the treatment of severe Covid-19 patients. This is a welcome development with the emerging prevalence of the Delta variant of the coronavirus, with top-line data expected to be shared in the near future.

    Additional Financials

    The company’s primary sources of revenue were generated from collaborative payments via clinical trial arrangements and grant awards. The three-month period ended June 30th, 2021 saw CAPR stock report USD$200,000 in revenue. This is up from the USD$50,000 reported as of June 30th, 2020. As of June 30th, 2021, the company reported cash and cash equivalents in the amount of USD$38.1 million.

    Future Outlook for CAPR

    CAPR stock reported promising developments over the course of the second quarter of fiscal 2021. The company is keen to leverage the resources at its disposal to ensure the continued trajectory of its success. Investors are hopeful for significant and sustained increases in shareholder value.

  • XL Fleet Corp. (XL) Stock Trends Lower After Disclosing Financial Reports for Q2 2021

    XL Fleet Corp. (XL) stock prices stayed stable over the course of August 13th 2021, ending the trading day at USD$7.10. Subsequent current market fluctuations have seen the stock fall by 10.70%, bringing it down to USD$6.34.

    XL Stock’s Revenue Reports

    The second quarter of fiscal 2021 reported revenue in the amount of USD$3.7 million. This is up from the USD$1.9 million reported in the second quarter of 2020. Revenue from the sale of drive systems in Q2 2021 was USD$1.3 million. This is comparable to the USD$1.9 million reported in Q2 2020. The year over year difference was largely attributable to microchip shortage and lack of new fleet chassis. Revenue from the XL grid came out to USD$2.4 million in Q2 2021, comprising of partial-quarter contribution from World Energy. The contribution from World Energy resulted from the business acquisition that took place on May 17th 2021.

    Gross Profit Breakdown

    Gross profit came out to USD$1 million for Q2 2021, up from the USD$0.04 million gross profit reported in the prior year period. The year over year increase was largely driven by XL Grid with the World Energy acquisition. Adjusted EBITDA was reported at negative USD$11.4 million for the quarter, as compared to negative USD$3.5 million reported in Q2 2020. This was a result of a substantial increase in the workforce, as well as an increase in service providers. These providers serve to support the company’s growth strategy and to meet its obligations as a publicly traded company.

    Additional Finances

    XL stock reported net loss for Q2 2021 in the amount of USD$10.5 million, down from the net loss of USD$13.5 million reported in Q2 2020. Net income for the 2021 quarter included a non-cash gain resulting from the change in fair value of warrant liability of USD$2.7 million. Adjusted net loss came out to USD$11.8 million for Q2 2021, up from the USD$5.3 million adjusted net loss reported for Q2 2020. The company reported a stellar liquidity position at the end of the second quarter, with cash and cash equivalents in the amount of USD$384.1 million as of June 30th 2021.

    Future Outlook for XL Stock

    The company reported a strong financial quarter, the success of which it hopes to continue through the upcoming quarters. XL stock is poised to capitalize on the opportunities afforded to it as the world heads towards a post-pandemic economy. Investors are hopeful that management will execute their business strategies so as to ensure increases in shareholder value.

  • Longeveron Inc. (LGVN) Stock Trending Higher Following Disclosure of Financial Reports for Q2 2021

    Longeveron Inc. (LGVN) stock prices stayed stable over the course of August 13th, 2021, ending the trading day at USD$5.41. Subsequent premarket fluctuations saw the stock rise by 1.48%, bringing it up to USD$5.49.

    Advancement of Clinical Trials

    The second quarter of fiscal 2021 saw LGVN stock report excellent progress in the advancement of the company’s Lomovel-B clinical research programs. The company announced encouraging top-line results from the Phase 2b Aging Frailty trial. The trial was designed to evaluate the safety and efficacy of four different doses of Lomecel-B compared to placebo in Aging Frailty subjects.

    Additional Developments

    The company expects to announce top-line results from their other Phase 1/2 Aging Frailty “HERA” trial during Q3 2-21. The company also hopes to initiate its Phase 2 Alzheimer’s disease trial, as well as a Phase 2 Japan Aging Frailty trial later in the year. LGVN stock also reported dosing the first patient in its Phase 2 Hypoplastic Left Heart Syndrome trial in June 2021. July 2021 saw the company report Phase 1 Alzheimer’s disease trial data at the AAIC. Accordingly, a manuscript of the results have been submitted for peer-review publication.

    LGVN Stock’s Solid Liquidity Position

    The culmination of the second quarter of fiscal 2021 saw LGVN stock report a solid liquidity position. The company reported cash on hand in the amount of USD$16.8 million as of June 30th, 2021. This is comparable to the USD$0.8 million reported as of June 30th, 2020. The year-over-year increase in cash on hand was largely facilitated by the completion of an IPO. The initial public offering was completed in February of 2021.

    LGVN Stock’s R&D Costs

    Research and Development costs for Q2 2021 were reported at USD$2 million. This is up from the USD$0.7 million reported in the prior-year quarter. The 205% year-over-year increase was largely attributable to the increase in R&D expenses that were not reimbursable by grants. This includes USD$0.8 million of equity-based compensation recorded for Restricted Stock Units, as well as stock options granted during the quarter.

    Future Outlook for LGVN Stock

    LGVN stock reported a promising financial quarter, the momentum of which it hopes to carry through the upcoming quarters. The company is keen to facilitate significant and sustained increases in shareholder value. Investors are confident in the company’s ability to continue their trajectory of success.

  • Venus Concept Inc. (VERO) Stock on the Rise Following Stellar Financial Reports for Q2 2021

    Venus Concept Inc. (VERO) stock prices were up by 2.45% as of the market closing on August 13th 2021. This brought the price per share down to USD$2.09 at the end of the trading day. Subsequent premarket fluctuations saw the stock surge by 12.92%, bringing it up to USD$2.36.

    VERO Stock’s Revenue Reports

    VERO stock reported total revenue in the amount of USD$25.8 million for the second quarter of fiscal 2021. This was a 52% increase from the numbers reported in the prior year quarter. The year over year increase in total revenue was largely driven by a 56% increase in international revenue, as well as a 48% increase in the United States revenue.

    Q2 2021 Revenue Breakdown

    This increase in regional revenue, in turn, was largely attributable to a 71% increase in lease revenue and a 29% increase in systems revenue. Further contributing to the difference was an 86% increase in products revenue and a 5% increase in services revenue. The percentage of total systems revenue generated from the company’s subscription model was up to 60%. This is compared to the 52% reported for the second quarter of 2020.

    Gross Profit and Margin

    Gross profit for the second quarter of 2021 was reported at USD$18.7 million. This is a 57% year-over-year increase. Gross margin was reported at 72.5% as compared to the 70% of revenue reported for the second quarter of 2020. The increase in gross margin was largely attributable to higher sales of Venus consumables. Also contributing to the year over year difference was an improved revenue mix of system sales sold under VERO stock’s subscription program, primarily tracing to Venus Bliss.

    VERO Stock’s Operating Income

    Operating income was down 17% for the second quarter of 2021, coming in at USD$17.2 million. The year over year decrease was largely attributable to the USD$6.8 million decrease general and administrative expenses. The 46% decrease reflects a positive USD$3.2 million bad debt recovery, as well as a USD$2.8 million gain on forgiveness of government assistance loans. These gains were partially offset by an increase of USD$5.6 million in sales and marketing costs, representing a 123% increase. Additionally offsetting the gains were a 29% increase in R&D expenses as compared to Q2 2020.

    Future Outlook for VERO Stock

    VERO stock reported a stellar financial quarter, with the company taking steps to maintain its momentum. The company is keen to continue its trajectory of success as the world hurtles towards a post-pandemic economy. Investors are confident in managements ability to leverage their resources to facilitate increases in shareholder value.

  • Honest Company Inc. (HNST) Stock Exhibits Minor Volatility Following Disclosure of Q2 2021 Financial Reports

    Honest Company Inc. (HNST) stock prices were up by 1.44% as of the market closing on August 13th 2021. This brought the price per share up to USD$14.05 at the end of the trading day. Subsequent premarket fluctuations saw the stock fall by 6.76%, bringing it down to USD$13.10.

    HNST Stock’s Strong H1 2021

    The company has reported the ongoing success of its strategic initiatives, with a focus on Content, Community, Commerce, and HSNT stock’s powerful innovation and category expansion. This has facilitated the strength of the company’s financial performance for the overall business over the course of the first half of 2021. The first half of fiscal 2021 reported 8% growth in revenue and volume. This is in addition to the accelerated Covid-19 stock-up surge of 25% revenue growth in the first half of 2020 as compared to the first half of 2019.

    Challenging Economic Environment

    HNST stock exceeded its expectation for gross margins for the overall business over the course of H1 2021. This reflects the company’s strength during a time of crisis for the entire industry. The ongoing coronavirus pandemic has resulted in challenging input costs, inventory and supply chain environment.

    Scope of HNST Stock’s Success

    The second quarter of 2021 saw HNST stock’s Clean Conscious Diaper report positive consumer response. Marketing innovation was also well-received with more than 17% retail consumption growth for the company Diapers, Wipes, and Personal Care products. This is measured by syndicated data for the thirteen week period ended June 27th 2021. This growth is on top of the surge of Diapers and Wipes products in 2020 as a result of the Covid-19 stock-up.

    Gross Margin Breakdown

    Gross margin for the second quarter of fiscal 2021 came in at 36%, down 50 basis points from numbers reported in the second quarter of 2020. Q2 2021 reports were a massive 710 basis points higher than numbers from the second quarter of 2019. Gross margin was up 110 basis points from the first quarter of 2021. The decline from Q2 2020 was largely attributable to the normalized levels of trade spend. The expansion in gross margin was also driven in part by the company’s cost-savings and product mix initiatives.

    Future Outlook for HNST Stock

    The company has reported strong financials for the second quarter of 2021 and is executing its strategy to continue its trajectory of success. The company is keen to usher in organic growth over the course of the pandemic and beyond. Shareholders are hopeful for consistent and significant increases in shareholder value.

  • Cricut Inc. (CRCT) Stock Dips Significantly Following the Disclosure of its Q2 2021 Financial Reports

    Cricut Inc. (CRCT) stock prices were up 3.26% as of the market closing on August 13th, 2021, bringing the price per share up to USD$34.51 at the end of the trading day. Subsequent premarket fluctuations saw the stock plummet by 16.02%, bringing it down to USD$28.98.

    Expansion of Product Portfolio

    The second quarter of fiscal 2021 saw CRCT stock launch Cricut Explore 3 and Cricut Maker 3. The expansion to their product portfolio included new physical hardware, software features, and content. The devices are designed to facilitate cutting that is twice as fast. Users are also afforded the ability to cut longer runs of materials, up to 12 feet in length.

    CRCT Stock Launches Smart Materials

    The company also launched a new line of Smart Materials. These are engineered to keep material perfectly aligned and on track from start to finish without the need for a cutting mat. The new Smart Materials are designed to facilitate an increase in use cases. The materials also provide an overall customer experience that cannot be matched by generic materials as they exist currently.

    Improved Consumer Experience

    Q2 2021 also saw CRCT stock add new software features and improved user experiences. These are designed to help drive user engagement in the company’s cloud-based software. The changes result in Design Space now including a new kerning feature. This feature enhances font usage while also saving time and increases use cases. Users were also introduced to new ways to easily organize their personal library of projects. The organization makes use of redesigned bookmark features and on-going search optimization efforts. Cricut Access, the company’s subscriptions service now has more than 175,000 images available, up 40% from the prior year quarter.

    CRCT Stock’s Global Expansion

    CRCT stock continues to target international markets as a key strategic focus area. To this end, the company launched a new direct to customer ecommerce site in the UK. The company also initiated its first sales team members in Italy and Mexico. The second quarter of 2021 saw the company continue to expand and consolidate its retailer footprint across Germany, France, Spain, South Africa, and Southeast Asia.

    Future Outlook for CRCT Stock

    CRCT is poised to capitalize on the return of the global economy to pre-pandemic levels as the world hurtles towards universal immunizations. The company is keen to set the stage for unprecedented growth once Covid-19 regulations and restrictions are mitigated. Investors are hopeful for significant and sustained increases in shareholder value.

  • Figs Inc. (FIGS) Stock Exhibits Minor Volatility Following Disclosure of Q2 2021 Financial Reports

    Figs Inc. (FIGS) Stock Exhibits Minor Volatility Following Disclosure of Q2 2021 Financial Reports

    Figs Inc. (FIGS) stock prices were up by 2.84% as of the market closing on August 12th, 2021. This brought the price per share up to USD$42.01 at the end of the trading day. Subsequent after-hours trading saw the stock dip by 9.31%, bringing it down to USD$38.10.

    Net Revenue Breakdown

    FIGS stock reported net revenues for the second quarter of fiscal 2021 in the amount of USD$101.1 million. This is a 57.6% increase from numbers reported for the period year quarter. The year-over-year difference is largely attributable to higher-order volumes reported for the quarter. Higher average order for the 2021 quarter also contributed to the yearly increase. The company reported a growth of 79.2% in its active customer base, which hit 1.6 million, as compared to numbers from the second quarter of 2020.

    FIGS Stock’s Gross Margins

    Gross margin was Q2 2021 was reported to have increased by 280 basis points as compared to Q2 2020. This brought the gross margin for the 2021 quarter up to 73.3%. The year over year increase is largely attributable to a transition of the sales mix from lower margin products towards higher margin scrubware. Further facilitating the year over year difference was a decrease in freight-in, owing to lower utilization of more expensive air freight.

    Net Loss Reports

    FIGS Stock reported net loss for the quarter in the amount of USD$40.5 million, down substantially from the net income of USD$14.2 million reported in Q2 2020. Net loss for the 2021 quarter was largely driven by USD$50.4 million of pre-tax stock-based compensation expense. This expense occurred in connection with FIGS stock’s recent public offering. Adjusted net income for the second quarter of fiscal 2021 came out to USD$14.3 million.

    EPS & EBITDA

    Earnings per diluted share came out to USD$0.26 for the 2021 quarter, a decrease from diluted EPS reported for Q2 2020. The year over year decrease was largely owing to decreases in net income, as well as a higher diluted share count. Adjusted EBITDA for Q2 2021 was up by 54.5%, coming in at USD$26.8 million. The year over year increase was largely due to higher order volumes, as well as higher average order values.

    Future Outlook for FIGS Stock

    FIGS stock is poised to capitalize on the momentum generated by its strong financial performance during Q2 2021. The company is keen to leverage the resources at its disposal, with investors hoping for a continued trajectory of success.